Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|1|1|1-5

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.1, Iss.1, 2004-01, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mapracorat, a Novel Non-Steroidal Selective Glucocorticoid Receptor Agonist for the Treatment of Allergic Conjunctivitis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 5, 2014-01 ,pp. : 289-298

Bentham Science Publishers

Access to resources Recommend Favorite

Novel class of non-steroidal progesterone receptor antagonists

By Zhi L.   Marschke K.B.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 695-700

Informa Healthcare

Access to resources Recommend Favorite

NPY Y1 and Y5 Receptor Selective Antagonists as Anti-Obesity Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-01 ,pp. : 1721-1733

Bentham Science Publishers

Access to resources Recommend Favorite

Non-steroidal glucocorticoid agonists

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 467-470

Informa Healthcare

Access to resources Recommend Favorite

New Highly Potent and Selective Adenosine A3 Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 8, 2004-04 ,pp. : 863-870

Bentham Science Publishers

Access to resources Recommend Favorite